Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats

Peptides

Volumn 24, Issue 3, 2003, Pages 477-481

  Chen, J C ^c   Tao, P L ^a   Li, J Y ^b   Wong, C H ^b   Huang, E Y K ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Behavior; Endomorphin 1; Endomorphin 2; Morphine; Neuropeptides; Opiate dependence; Withdrawal syndromes

Indexed keywords

ENDOMORPHIN 1; ENDOMORPHIN 2; MORPHINE; NALOXONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUXISM; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG POTENCY; GROOMING; JUMPING; MALE; MASTICATION; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; PROVOCATION TEST; PTOSIS; RAT; REARING; SCORING SYSTEM; SNIFFING; STRETCHING; WET DOG SHAKES; WITHDRAWAL SYNDROME; YAWNING;

CANIS FAMILIARIS; POROMITRA OSCITANS;

EID: 0038066385     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00078-0     Document Type: Article

References (21)

1. Atherton E, Sheppard RC. Solid phase peptide synthesis, a practical approach. New York: IRL Press at Oxford University Press; 1989.
2. Bloom F.E. The endorphins: a growing family of pharmacologically pertinent peptides. Ann. Rev. Pharmacol. Toxicol. 23:1983;151-170.
3. Csullog E., Joo G., Toth G., Dobos I., Benedek G., Horvath G. Antinociceptive effect of continuous intrathecal administration of endomorphin-1. Pain. 94:2001;31-38.
4. Goldstein A., Tachibana S., Lowney L.I., Hold L. Dynorphin - (1-13), an extraordinary potent opioid peptide. Proc. Natl. Acad. Sci. USA. 76:1979;6666-6670.
5. Horvath G., Szikszay M., Tomboly C., Benedek G. Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats. Life Sci. 65:1999;2635-2641.
6. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan G.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577.
7. Nakanishi S., Inoue A., Kita T., Chang A.C.Y., Cohen S., Numa S. Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor. Nature. 257:1979;238-240.
8. Narita M., Funada M., Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89:2001;1-15.
9. Narita M., Ozaki S., Ioka M., Mizoguchi H., Nagase H., Tseng L.F.et al. Different motivational effects induced by the endogenous μ-opioid receptor ligands endomorphin-1 and -2 in the mouse. Neuroscience. 105:2001;213-218.
10. 1-opioid receptor subtype on motivational effects induced by the endogenous μ-opioid receptor ligands endomorphin-1 and -2 in the mouse. Neurosci. Lett. 308:2001;17-20.
11. Ohsawa M., Mizoguchi H., Narita M., Chu M., Nagase H., Tseng L.F. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther. 294:2000;1106-1111.
12. Ohsawa M., Mizoguchi H., Narita M., Nagase H., Kampine J.P., Tseng L.F. Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. J. Pharmacol. Exp. Ther. 298:2001;592-597.
13. Pasternak G.W. Insights into mu opioid pharmacology the role of mu opioid receptor subtypes. Life Sci. 68:2001;2213-2219.
14. Pinelli A., Trivulzio S., Tomasoni L. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats. Eur. J. Pharmacol. 340:1997;111-119.
15. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York, NY: Academic Press; 1986.
16. Sakurada S., Zadina J.E., Kastin A.J., Katsuyama S., Fujimura T., Murayama K.et al. Differential involvement of μ-opioid receptor subtypes in endomorphin-1 and -2-induced antinociception. Eur. J. Pharmacol. 372:1999;25-30.
17. Sakurada S., Hayashi T., Yuhki M., Orito T., Zadina J.E., Kastin A.J.et al. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur. J. Pharmacol. 427:2001;203-210.
18. Soignier R.D., Vaccarino A.L., Brennan A.M., Kastin A.J., Zadina J.E. Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice. Life Sci. 67:2000;907-912.
19. Tan P.P.-C., Chen J.-C., Li J.-Y., Liang K.-W., Wong C.-H., Huang E.Y.-K. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs. Peptides. 20:1999;1211-1217.
20. Wilson A.M., Soignier R.D., Zadina J.E., Kastin A.J., Nores W.L., Olson R.D.et al. Dissociation of analgesic and rewarding effects of endomorphin-1 in rats. Peptides. 21:2000;1871-1874.
21. Zadina J.E., Hackler L., Ge L.-J., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.